Despite the continued importance of tuberculosis as a world-wide threat to public health, little is known about the mechanisms used by human lymphocytes to contain and kill the intracellular pathogen Mycobacterium tuberculosis. We previously described an in vitro model of infection of human monocytes (MN) with virulent M. tuberculosis strain H37Rv in which the ability of peripheral blood lymphocytes to limit intracellular growth of the organism could be measured. In the current study, we determined that lymphocyte- 
Tuberculosis remains a major international health problem which is likely to become even more significant in coming years because of the high prevalence of human immunodeficiency virus (HIV) disease in regions where infection with the intracellular pathogen Mycobacterium tuberculosis is endemic. Although it is estimated that one-third of the world's population is currently infected with M. tuberculosis (40) , the great majority of these individuals never develop active disease, indicating the ability of human immune responses to contain the organism. Despite the importance of M. tuberculosis infection, little is known about the mechanisms that serve to contain this pathogen. Lymphocytes are thought to activate M. tuberculosisinfected mononuclear phagocytes to mediate the killing of intracellular bacteria, but the killing of M. tuberculosis has not been widely studied as an indicator of protective immunity. Although CD4, CD8, and ␥␦ lymphocytes exhibit proliferative, cytokine, and cytotoxic responses following stimulation by whole M. tuberculosis or its antigens (4, 8, 12, 41, 42) , these responses have generally not been correlated with bacterial killing. On the other hand, killing of intracellular Mycobacterium bovis BCG and M. tuberculosis has been assessed in response to various chemical mediators of cell death. These studies have indicated that necrotic death of infected monocytes does not result in killing of intracellular M. tuberculosis, whereas apoptotic cell death does result in bacterial killing (21, 25) . However, with the exception of one report involving cell lines restricted to the unusual CD1 antigen-presenting pathway (39) , these cytotoxic mechanisms have not been investigated in the context of specific lymphocyte populations capable of mediating killing of intracellular M. tuberculosis.
We previously described an in vitro model of reproducible infection of human monocytes (MN) with virulent M. tuberculosis strain H37Rv in which the ability of peripheral blood lymphocytes (PBL) to limit intracellular growth of the organism could be demonstrated (36) . In the current study, we determined that killing of intracellular M. tuberculosis occurred within the first 24 h of coculture of infected MN with unstimulated PBL, which implied a role for innate immune responses in containment of intracellular M. tuberculosis. Natural killer (NK) cells represent a population of lymphocytes which could mediate innate protection against M. tuberculosis. NK cells have been implicated in early immune responses to viruses and to a variety of intracellular pathogens and are capable of rapidly producing gamma interferon (IFN-␥) as well as lysing specific target cells in the absence of prior activation (2, 6, 31, 32) . More recently, NK cells also have been shown to express several surface ligands capable of initiating apoptosis (9, 29, 46) . We therefore investigated the ability of NK cells to mediate the killing of intracellular M. tuberculosis following 24 h of coculture with infected MN, and we sought to correlate this killing with the production of IFN-␥, granule-mediated lysis of infected MN, and the induction of MN apoptosis.
MATERIALS AND METHODS

Donors.
Subjects were paid healthy volunteers between the ages of 22 and 50. For some studies, purified protein derivative (PPD)-positive subjects were specifically recruited. All protocols were approved by the Institutional Review Board of University Hospitals of Cleveland. Informed consent was obtained from each subject.
Cultivation and processing of mycobacteria. Broth cultures of M. tuberculosis strain H37Rv and the attenuated vaccine strain M. bovis BCG Pasteur (strains 25618 and 35734, respectively, American Tissue Type Collection [ATCC], Rockville, Md.), were grown in sterile Middlebrook 7H9 medium with 10% Middlebrook ADC enrichment and 0.2% glycerol. Plated cultures were grown on Middlebrook 7H10 agar with 10% Middlebrook OADC enrichment (Difco, Detroit, Mich.) and 0.5% glycerol.
H37Rv and BCG were initially grown to mid-log phase as broth cultures in 1.7-liter rolling bottles (no. 2528-1700; Corning, Corning, N.Y.) at 37°C. Cultures were divided into aliquots and immediately stored at Ϫ70°C. These aliquots were used to inoculate all subsequent roller bottle cultures for use in the infection of MN so that all infections were performed with organisms which had undergone only one previous laboratory passage. In preparation for the infection of MN, mycobacteria were processed using a series of mechanical disruptions and centrifugations based on the methods of Schlesinger (33) and previously described in detail (36) , which served to minimize clumping and to provide for accurate quantification of the inoculum.
Isolation of blood MN and lymphocytes. Peripheral blood was obtained by venipuncture from healthy individuals and, mononuclear cells were isolated by density sedimentation using Ficoll-Hypaque (Ficoll-Paque, Pharmacia, Uppsala, Sweden) and washed three times in RPMI 1640 (BioWhittaker, Walkersville, Md.). Peripheral blood mononuclear cells (PBMC) were incubated in tissue culture-grade 100-mm polystyrene petri dishes (Falcon 3003; Becton Dickinson Labware, Lincoln, N.J.) to separate adherent MN and nonadherent PBL populations as previously described (36) .
Isolation of human NK cells. NK cells were isolated from blood lymphocytes using a two-step method. First, CD56 ϩ cells were positively selected using anti-CD56 antibodies in a MACS magnetic column separation system (Miltenyi Biotech, Auburn, Calif.). Each portion of 10 8 PBL was resuspended in 800 l of MACS buffer (phosphate-buffered saline with 0.5% bovine serum albumin and 2 mM EDTA) and incubated with 200 l of MACS CD56 MicroBeads (no. 504-01) for 15 min at 4°C. Cells were washed with 10 to 20 ml of MACS buffer and resuspended in 1 ml of buffer. Blood lymphocytes were then added to a MACS MS separation column (no. 422-01) on a MiniMACS magnet that had been precooled for 20 min at 4°C and primed with 500 l of buffer. Lymphocytes were allowed to run through the column, which was then washed three times with 500 l of buffer. The column was then removed from the magnet. After the addition of 1 ml of buffer, a plunger was used to expel positively selected cells into 5-ml polystyrene tubes.
The selected population of CD56 ϩ lymphocytes was further purified by removing residual CD3 ϩ cells using Dynabeads M-450 CD3 (no. 111.13; Dynal). Beads were washed with medium and added to the CD56 ϩ population for a 45-min incubation on a rotating platform at 4°C. CD3 ϩ cells were removed using a Dynal magnetic particle separator. Two-color fluorescence-activated cell sorter analysis using CD3-fluorescein isothiocyanate (FITC) and CD56-Phycoerythrin (PE) (no. 340542 and no. 347747, respectively; Becton Dickinson) confirmed that the resulting cell populations consistently contained Ͼ95% CD3 Ϫ CD56 ϩ NK cells.
Infection of human MN with M. tuberculosis and assessment of intracellular growth. Isolated MN were resuspended at a density of 10 6 /ml in Iscove's modified Dulbecco's medium with NaHCO 3 , 25 mM HEPES, 1% L-glutamine (subsequently referred to here as IMDM; BioWhitakker 12-722F) with 5% fresh autologous serum (without antibiotics), and 100 l (10 5 monocyctes) were divided into aliquots in triplicate wells of round-bottomed 96-well plates (Corning) for CFU assessment for each time point to be studied. Following overnight incubation to allow for readherence, the supernatants were removed and H37Rv was added, in a 1:1 bacterium-to-MN infecting ratio, in 100 l of IMDM per well with 30% autologous serum. Plates were returned to a 37°C incubator for 1 h, at which time the supernatants were aspirated, and each well was washed three times with RPMI 1640 and 10% fetal calf serum and 1% HEPES to remove noningested mycobacteria. Wells were then refilled with 200 l of IMDM and 10% non-heat-inactivated autologous serum.
At selected time points, supernatants from the appropriate triplicate wells were aspirated and saved. Cell pellets were lysed with 0.067% sodium dodecyl sulfate (SDS), pooled, and diluted for plating onto 7H10-OADC plates for CFU determination as previously described in detail (36) . The results were expressed as CFU per milliliter of lysate, which corresponded to CFU/10 6 cultured MN. Addition of blood lymphocytes and NK cells to infected MN. PBL were resuspended in IMDM containing 10% fresh autologous serum and stored in a 37°C CO 2 incubator during the readherence of MN into microtiter wells. The next morning, the lymphocytes were washed and resuspended at a density of 5 ϫ 10 6 /ml in IMDM with 10% autologous serum. Lymphocytes were then added to autologous MN cultures immediately following the rinsing of nonphagocytosed bacteria. The addition of 200 l of PBL (for a 10:1 PBL/monocyte ratio) was utilized in order to reconstitute the approximate composition of the PBMC. Various ratios of NK cells were added to autologous infected MN to determine dose-response effects as described in Results.
M. tuberculosis-induced production of IFN-␥ by lymphocyte populations and blocking of IFN-␥. Supernatants were collected from cocultured M. tuberculosisinfected human MN and PBL or NK cells after 24 and 96 h of culture. Samples were frozen at Ϫ70°C until use, at which time they were thawed and filtered through 0.22-m (pore-size) filters to remove residual organisms. IFN-␥ concentrations in supernatants were measured using a commercially available enzyme-linked immunosorbent assay (ELISA) kit (EH-IFN␥; Endogen, Cambridge, Mass.). ELISA plates were read using an automated plate reader (Molecular Devices Corp., Menlo Park, Calif.) and a dual-wavelength reading at ϭ 450/570. In blocking studies, neutralizing polyclonal antibody to human IFN-␥ (Endogen P-700) was added to cultures at a concentration of 10 g/ml.
Supernatant transfer studies. Supernatants were collected from 96-well microtiter cocultures of NK cell, and M. tuberculosis-infected human monocytes were established in the fashion described above. Supernatants removed after 6, 18, and 24 h of coculture were filtered to remove residual organisms and added to freshly infected MN from the same subjects. The CFU counts were determined at 24 h of culture, and the supernatant-mediated reduction in intracellular M. tuberculosis was compared to that observed in cocultures of M. tuberculosisinfected MN cocultured with NK cells.
Assessment of the requirement for direct contact between NK cells and M. tuberculosis-infected MN in killing of intracellular bacilli. Dual-chamber studies were established using 24-well Transwell plates (no. 3413; Costar, Cambridge, Mass.). A total of 6 ϫ 10 5 MN was added to the lower chamber of each well and infected with M. tuberculosis using a 1:1 bacterium-to-cell ratio as described above. For each subject, 3 ϫ 10 6 NK cells were then added to the upper chamber of one well (separated from the infected MN by a 0.4-m [pore size] membrane) and directly to infected MN in the lower chamber of another well. After 24 h of coculture, lower-chamber cells were lysed to allow for CFU determination. Intracellular M. tuberculosis levels in cultures of MN alone were compared to those within cultures in which NK cells were added in direct contact with infected MN and to wells in which NK cells were separated by membrane filters from the MN.
Assessment of NK cell-mediated cytotoxicity. NK cell activity was measured using the standard target K562 human leukemia cell line (no. 45506; ATCC) in a chromium release assay using radioactive 51 Cr. K562 cells were labeled with 100 Ci of 51 Cr (1 mCi/ml; ICN Radiochemicals, Irvine, Calif.) for 2 h at 37°C, washed four times, and resuspended in 10% fetal calf serum at 10 5 cells/ml, of which 3,000 to 5,000 cell aliquots were plated into 96-well round-bottomed plates. NK cells were added to the wells in various effector/-target ratios (1:1, 5:1, and 20:1). Plates were centrifuged at 200 ϫ g for 30 s and incubated at 37°C for 4 h. Supernatants were harvested and 51 Cr release measured by using a gamma counter. The spontaneous release of 51 Cr was measured in wells containing target cells alone. The maximum release was determined from target cells which had been lysed with 3% SDS. The percent specific 51 Cr release was calculated for each experimental group by using the following equation: percent specific release ϭ [(cpm experimental Ϫ cpm spontaneous release)/(cpm maximum release Ϫ cpm spontaneous release)] ϫ 100.
Inhibition of exocytosis of NK cell cytotoxic granules. For some studies, NK cell granule release was inhibited using the calcium chelator EGTA (E 0396; Sigma, St. Louis, Mo.). For cytotoxicity studies, NK cells were resuspended in medium containing 5 mM EGTA prior to the addition to K562 cells, and the specific 51 Cr release determined as described above. In CFU studies, NK cells were resuspended in IMDM containing 5 mM EGTA prior to the addition to M. tuberculosis-infected MN. Control studies adding IMDM with EGTA to infected MN alone were also performed.
Measurement of NK cell-induced MN apoptosis. NK-cell mediated apoptosis of mycobacterium-infected MN was measured using FITC labeling of DNA strand breaks with a commercially available TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling) assay (In Situ Cell Death Detection Kit 1684795; Boehringer-Mannheim, Indianapolis, Ind.). In order to accurately quantify apoptosis in a mixed cell system, MN were also labeled using CD14-PE (no. 347497; Becton Dickinson) and analyzed by two-color flow cytometry. Because of the need to perform flow cytometry outside of a biosafety level 3 facility, MN were infected with M. bovis BCG for these studies. MN were placed in polypropylene tubes and incubated for 1 h with BCG in IMDM with 30% autologous serum in a 10:1 bacterium-to-cell ratio. Infected MN were then pelleted by centrifugation at 480 ϫ g and resuspended in IMDM with 10% serum. NK cells were added to infected autologous MN in a 5:1 ratio and incubated for 24 h. Uninfected MN, BCG-infected MN, and uninfected MN cocultured with NK cells were incubated as well for use as controls. Cells were labeled with anti-CD14 and fixed with 2% paraformaldehyde prior to permeabilization and labeling for apoptosis with the TUNEL reagent according to the manufacturer's protocol.
To assess apoptosis within MN cultures infected with virulent M. tuberculosis, in situ TUNEL assays were performed using three-color fluorescent microscopy. To allow for recognition of infected cells stained with both CD14-PE and TUNEL-FITC, H37Rv was labeled with the amine-reactive fluorescent blue dye AlexaFluor 350 carboxylic acid, succinimidyl ester (A10168; Molecular Probes, Eugene, Oreg.). Bacilli were washed and resuspended in PBS (pH 8.7; adjusted by the addition of 1 M sodium bicarbonate buffer). AlexaFluor 350 solution was prepared according to the manufacturer's recommendations by dissolving 5 g of the dye in 500 l of dimethyl sulfoxide. Then, 25 l of this solution was added to 450 l of H37Rv. Following a 30-min incubation at room temperature, H37Rv was washed three times and diluted to the appropriate concentration for infection of MN in the same manner as that described for BCG above. NK cells were then added to cultures in a 5:1 ratio relative to the number of infected MN. Following 24 h of coculture, this preparation was incubated with CD14-PE, washed, and fixed by overnight incubation with 2% paraformaldehyde. The next day, cells were counted, and cytospin slides were prepared using 50,000 cells per slide. In situ TUNEL assessment of apoptosis was the performed according to the manufacturer's protocol (Boehringer-Mannheim). Fluorescent micrograph images using appropriate filters for each color were obtained using a digital camera (Spot Digital Camera; Diagnostic Instruments, Sterling Heights, Mich.), and composite three-color micrographs were assembled using Spot Advanced Software (Diagnostic Instruments).
Blocking of Fas-FasL interaction. Blocking anti-FasL monoclonal antibody NOK1 (Pharmingen, San Diego, Calif.) was added in final concentration of 10 g/ml to assays of both NK cell-mediated killing of intracellular M. tuberculosis H37Rv and NK cell-induced apoptosis of BCG-infected MN. Results were determined by CFU assay and TUNEL assay, respectively, as described above. As a control for the efficacy of blocking of FasL by NOK1, the antibody was also added to cultures in which a previously described FasL-expressing transfectant KFL9 (35) was incubated with Jurkat target cells. The ability of KFL9 to induce apoptosis of Jurkat cells in the presence of medium alone and with the addition of 10 g of NOK1 per ml was assessed by the TUNEL method. Cells were incubated with anti-CD54-PE prior to the TUNEL procedure in order to distinguish the two cell populations. Apoptosis of Jurkat was calculated as percentage of CD54-negative cells that stained positively with the TUNEL reagent.
Assessment of the effects of blocking multiple NK cell effector pathways simultaneously. To evaluate the possibility that multiple effector functions of NK cells function cooperatively to result in the killing of intracellular M. tuberculosis, we assessed the results of simultaneously blocking IFN-␥ with the antibody P-700 (again at concentration 10 g/ml), granule release with 5 mM EGTA, and Fas-FasL interactions with the anti-FasL antibody NOK1 (10 g/ml). The effects of each pair of these inhibitors upon NK cell-mediated killing of intracellular M. tuberculosis was determined at 24 h of coculture, as was the effect of simultaneous addition of all three inhibitors to the cultures.
Statistics. All statistical comparisons were made using paired t tests and calculated on Prism software (GraphPad Software, San Diego, Calif.). Figure 1 shows the results for studies of five subjects and indicates consistent reduction of intracellular M. tuberculosis within the first 24 h after the addition of PBL to infected MN (P ϭ 0.006 compared to CFU within MN alone). Following this 9.6-fold early reduction, growth of M. tuberculosis both within MN alone and within MN cocultured with PBL were essentially the same through days 2 to 4 (2.6-fold growth versus 3.3-fold growth, respectively). The finding of killing within 24 h of the addition of unprimed lymphocytes suggested a role for innate immune responses such as those mediated by NK cells in the early inhibition of intracellular M. tuberculosis.
RESULTS
PBL mediate killing of intracellular
Isolated human NK cells can mediate early killing of intracellular M. tuberculosis. Flow cytometry confirmed that the two-step enrichment procedure described above consistently yielded a cell population composed of greater that 95% CD3 Ϫ
CD56
ϩ lymphocytes, which are subsequently referred to as NK cells.
In initial studies, NK cells were added in ratios of 1:1, 3:1, and 5:1 to M. tuberculosis-infected MN. As illustrated in Fig. 2 , NK cells were able to mediate killing of intracellular M. tuberculosis within 24 h of coculture, and the magnitude of this effect increased with increasing ratios of NK cells relative to M. tuberculosis-infected MN. The reductions in intracellular M. tuberculosis-mediated by NK cells in both 3:1 and 5:1 ratios were statistically significant (P ϭ 0.006 and P ϭ 0.003, respectively). In order to maximize our ability to assess the mechanisms involved in this killing, the 5:1 ratio of NK cells to infected MN was used in all subsequent studies. Donor-todonor variability can be substantial in human studies of mycobacteria, as indicated by large standard deviations, particularly of CFU of infected MN alone. Nevertheless, we found that relatively low numbers of subjects were required to demon- strate statistically significant effects of NK cells on the viability of intracellular M. tuberculosis in the various studies described.
To confirm that our NK cell-enriched cell populations were effectively depleted of antigen-specific immune responses to M. tuberculosis, we compared the effects of the addition of NK cells obtained from PPD-positive and PPD-negative donors to M. tuberculosis-infected MN. As shown in Fig. 3 , NK cells from both subject groups mediated killing of intracellular H37Rv. The magnitude of M. tuberculosis killing following the addition of NK cells from the two groups was similar, since NK cells of PPD-positive subjects mediated 63% reduction in intracellular M. tuberculosis compared to CFU within infected MN alone (P ϭ 0.036, Fig. 3A) , whereas NK cells from PPD-negative subjects mediated 70% reduction in CFU (P ϭ 0.013, Fig. 3B ).
Killing of intracellular M. tuberculosis by NK cells is not associated with IFN-␥ production. Because early production of IFN-␥ has been demonstrated to be essential for NK cellmediated protection against other pathogens, we sought to determine whether IFN-␥ played a role in the ability of these cells to mediate killing of intracellular M. tuberculosis. IFN-␥ was measured in supernatants collected at 24 and 96 h from cultures of M. tuberculosis-infected MN alone and of infected MN cocultured with either PBL or isolated NK cells. As illustrated in Fig. 4A , none of the cell populations studied produced detectable quantities of IFN-␥ following 24 h of coculture with M. tuberculosis-infected MN. NK cells also produced only minimal amounts of IFN-␥ at 96 h of coculture with M. tuberculosis-infected MN (37 Ϯ 36 pg/ml), whereas PBL produced substantial amounts of the cytokine (683 Ϯ 149 pg/ml, P ϭ 0.0002 compared to infected MN alone).
To rule out the possibility that NK-cell mediated killing of intracellular M. tuberculosis could be mediated by local IFN-␥ production not detectable by ELISA, we added anti-IFN-␥ blocking antibody to cultures. As indicated in Fig. 4B H37Rv at 24 h, whereas the addition of NK cells from PPD-negative donors mediated a 70% reduction in the organism. The NK cellmediated reduction in intracellular M. tuberculosis compared to CFU within MN alone was significant for both groups of subjects (P ϭ 0.036 for PPD-positive subjects; P ϭ 0.013 for PPD-negative subjects). The graphs illustrate the mean and SD for five subjects in each group. cells mediated significant killing of intracellular M. tuberculosis (P ϭ 0.012) at 24 h. In contrast, the addition of supernatants collected at 6, 18, and 24 h of coculture did not result in significant reduction of intracellular M. tuberculosis compared to that observed in infected MN alone (P ϭ 0.136, P ϭ 0.410, and P ϭ 0.471, respectively). Inhibition of granule release does not affect the ability of human NK cells to kill intracellular M. tuberculosis. Because a major effector mechanism of NK cells is that of granule-mediated cytotoxicity, we sought to determine whether this pathway was involved in NK cell-mediated killing of intracellular M. tuberculosis The calcium chelator EGTA inhibits granule release from NK cells and was therefore used to investigate the role of granules in the killing of H37Rv. As illustrated in Fig.  7A, CD3 Ϫ CD56 ϩ NK cells lyse the standard NK target K562 line in a dose-dependent fashion. In the presence of 5 mM EGTA, granule-dependent lysis was completely inhibited, indicating that this concentration of EGTA effectively blocked calcium-dependent granule release and activity. Parallel CFU studies were performed simultaneously using NK cells from the same subjects in order to assess the effects of blocking of granule release on the ability of NK cells to kill intracellular M. tuberculosis H37Rv (Fig. 7B) . We found that 5 mM EGTA itself had no direct effect on the intracellular growth of M. tuberculosis, as illustrated. NK cells in medium reduced the CFU level of intracellular H37Rv by 83% compared to the ϩ MN which were undergoing apoptosis. Because flow cytometry cannot be performed in our biosafety level 3 facility, we infected MN with the attenuated strain M. bovis BCG rather than H37Rv for these studies. Representative results are displayed in Fig. 8 . MN apoptosis, represented by dual staining with CD14-PE and TUNEL-FITC, was minimal within BCG-infected MN alone at 24 h after infection (Fig. 8A) . The addition of NK cells, however, increased the percentage of apoptotic MN from Ͻ1% to 18.9% in this subject (Fig. 8B) . Table 1 summarizes the mean results of TUNEL assays from separate experiments using NK cells from four donors. As shown, apoptosis was minimal (1.4%) in uninfected MN and was not significantly increased in BCGinfected MN (3.5%, P ϭ 0.100). The addition of NK cells to uninfected MN significantly increased apoptosis to 11.5% of MN (P ϭ 0.014 compared to MN alone), and apoptosis of BCG-infected MN following the addition of NK cells increased to 21.4% (P ϭ 0.009 compared to BCG-infected MN alone, P ϭ 0.005 compared to uninfected MN incubated with NK cells).
Because it has been reported that virulent M. tuberculosis, in comparison to BCG, renders infected cells resistant to apoptosis (1), we made use of an in situ TUNEL assay to confirm that NK cells also induced the apoptosis of H37Rv-infected MN. As the fluorescent micrograph shown in Fig. 9 of intracellular M. tuberculosis using the neutralizing anti-FasL antibody NOK1 (10 g/ml). As shown in Fig. 10A , the addition of NOK1 had no effect on the ability of NK cells to kill intracellular H37Rv. For the studies of the four subjects illustrated, NK cells alone mediated 51.1% reduction in intracellular H37Rv compared to MN alone (P ϭ 0.018). In the presence of NOK1, The CFU of intracellular M. tuberculosis was reduced by 56.2% by NK cells (P ϭ 0.014). Figure 10B illustrates the effects of NOK1 on apoptosis. Induction of apoptosis of Jurkat cells by the FasL transfectant KFL9 was significantly inhibited by the addition of NOK1, since the percentage of TUNELpositive Jurkat cells decreased from 45.3 to 17.1% (P ϭ 0.039). In contrast, NK cell-mediated apoptosis of BCG-infected MN was not inhibited by NOK1 (27.7% in medium alone versus 25.8% with NOK1; P ϭ 0.227). Thus, both apoptosis of BCGinfected MN and killing of intracellular M. tuberculosis by NK cells are mediated by pathways other than those initiated by the interaction of FasL and Fas.
NK cell-mediated killing of intracellular M. tuberculosis is not blocked by the simultaneous blocking of NK cell granule release, IFN-␥, and Fas-FasL. To rule out the possibility that multiple mechanisms contributing to NK cell-mediated killing of M. tuberculosis must be blocked simultaneously in order to inhibit the observed killing, we studied the effects of EGTA treatment and the use of neutralizing antibodies to IFN-␥ and FasL in various combinations (Fig. 11) . In the presence of the various combinations of two of the three inhibitors, as well as the simultaneous blockage of all three pathways, NK cells retained their ability to mediate significant reduction in intracellular M. tuberculosis compared to CFU within MN alone, as illustrated (P Ͻ 0.001 in each case).
DISCUSSION
Human cell-mediated immunity to M. tuberculosis is assumed to involve the ability of lymphocytes to activate infected mononuclear phagocytes, resulting in the killing of intracellular bacilli. Nevertheless, studies of the role of lymphocyte responses to M. tuberculosis and its antigens have generally not addressed the correlation between the various responses of these cells and bacterial killing. In this study, we demonstrated that human NK cells can mediate the early killing of intracellular M. tuberculosis, and we examined the relationship between the various innate immune functions of NK cells and this killing.
Studies of protective human responses to M. tuberculosis have largely focused on healthy PPD-positive individuals who are considered to have developed specific immunity to M. tuberculosis PPD-positive individuals display resistance to reinfection upon subsequent exposure to M. tuberculosis (37) , and the remarkable susceptibility of HIV-infected individuals with dysfunction and depletion of CD4 ϩ T cells provides strong support for the concept that antigen-specific responses play a major role in resistance to M. tuberculosis (15, 24) . However, a role for innate immune responses in protection against M. tuberculosis has been suggested as well by clinical scenarios in which heavily exposed individuals do not develop PPD reactivity (16) and by the observation that some PPDnegative individuals display in vitro responses to M. tuberculosis (18, 30) . Our finding that unprimed human PBL mediated the killing of the intracellular M. tuberculosis within 24 h of coculture with infected MN implied a role for innate immunity in this process. Several effector functions of NK cells may serve to mediate innate immune responses. The "NK activity" which led to the initial identification of this cell population specifically refers to the ability of nonprimed cells to lyse target cells in an HLA-unrestricted manner (31) . Furthermore, NK cells can be activated by infected MN independently of specific antigen recognition by cytokines such as interleukin-12 (IL-12), IL-15, and IL-18 (10, 20, 43) . Activated NK cells can serve as early sources of IFN-␥ (28, 32, 38) and of proinflammatory chemokines such as MIP1␣ (7).
We observed that unstimulated NK cells could mediate killing of intracellular H37Rv at 24 h of coculture in a dosedependent fashion. Previous studies have reported that NK cells can inhibit intracellular growth of M. avium (5) and the avirulent M. tuberculosis strain H37Ra (45) . Although killing of a recent clinical isolate of M. tuberculosis by IL-12-stimulated NK cells has also been observed (13) , the current findings provide the first report of the ability of unstimulated NK cells to mediate the killing of a well-characterized virulent strain of M. tuberculosis. Our subsequent studies were aimed at identifying the mechanisms by which this killing occurred. The antimicrobial functions of NK cells have been studied in murine models of infection with a wide variety of intracellular pathogens. The production of IFN-␥ by NK cells plays an essential role in the containment of murine infection with cytomegalovirus, listeria, and various intracellular parasites (3, 28, 32) . In contrast, we observed that the killing of intracellular H37Rv by human NK cells was not associated with the production of IFN-␥. The finding that neutralizing antibodies to IFN-␥ had no effect on NK cell-mediated killing of M. tuberculosis further rules out a role for IFN-␥ in this process. These observations are consistent with an earlier report that PPD does not induce human NK cells to produce IFN-␥ unless activated T cells are present as well (19) . Our subsequent studies involving both the transfer of supernatants of cocultured NK cells and M. tuberculosis-infected MN and the assessment of NK cell activity in Transwell cultures further indicate that NK cell-mediated killing of intracellular M. tuberculosis cannot be attributed to the effects of soluble mediators. We therefore investigated the role of the cytotoxic effector functions of human NK cells in the killing of intracellular M. tuberculosis.
Because NK cell cytotoxicity has classically been attributed to the release of cytotoxic granules containing perforin and other effector molecules (17), we next sought to determine whether granule release was essential for NK cell-mediated killing of intracellular M. tuberculosis. Free calcium is required for the exocytosis of NK cell cytotoxic granules, and the calcium chelator EGTA has therefore been utilized to demonstrate granule-independent effects of NK cells (44) . The addition of EGTA to our cultures blocked the granule-mediated lysis of K562 targets by NK cells but had no effect on the ability of NK cells to kill intracellular H37Rv. These findings indicate that the killing of M. tuberculosis by NK cells is independent of granule exocytosis. Our observations contrast with those reported in studies of CD1-restricted cytotoxic T-cell lines recognizing lipid and lipoglycan antigens of M. tuberculosis (39) . The CD1-restricted lymphocytes were found to comprise two distinct populations that exhibited differing patterns of cytotoxicity. CD4 Ϫ CD8 ϩ lymphocytes killed infected MN by granule-mediated cytotoxicity that resulted in the killing of intracellular M. tuberculosis, whereas CD4 Ϫ CD8 Ϫ lymphocytes killed infected MN via Fas-FasL-induced apoptosis and had no effect on the viability of the organism. The clinical significance of CD1-restricted lymphocytes remains uncertain, however, and it has recently been suggested that the CD1 pathway may in fact be coopted by M. tuberculosis in order to facilitate bacterial survival (34) . Our assessment that cytotoxic granules do not play a role in the killing of M. tuberculosis by NK cells is consistent with two studies which reported that the course of M. tuberculosis infection in perforin knockout mice does not differ from that observed in wild-type animals (11, 22) , as well as with the observation that chemically induced necrosis of BCG-infected human MN does not result in the killing of intracellular organisms (25) . An earlier report by Molloy et al. found that human LAK cells lysed BCG-infected MN but that lysis did not result in the killing of the organism (26) . Although a large proportion LAK precursors are CD56 ϩ CD3 Ϫ NK cells, the authors' observation that the cells with lytic activity specific for mycobacterium-infected cells were CD56 Ϫ CD3 ϩ emphasizes the fact that an IL-2-stimulated LAK population is not equivalent to the isolated NK cells we studied. In addition, IL-2 stimulation may not enhance the other activities of LAK precursor cells as it does their capacity for cytolysis. The culture conditions used in that study also differed from ours in that LAK cells were added to MN 6 days after infection, at which time the infected cells were reported to contain an average of 10 to 20 bacilli. This level of infection could have resulted in a model system more conducive to cell lysis and less so to bacterial killing than the early, low-level infection model we studied. The finding that NK cells induce apoptosis of BCG-infected MN is intriguing as a possible mechanism of NK cell-mediated bacterial killing in light of previous studies of cytotoxicity directed at MN infected with both M. bovis BCG (21, 25) and M. tuberculosis (27) . These investigations showed that chemicalor cytokine-induced apoptosis of the infected cells was associated with decreased viability of the mycobacteria within the target MN. Although the protocol used in these studies resulted in the infection of 65 to 75% of monocytes, only 21% of monocytes were found to be apoptotic by TUNEL analysis after 24 h of coculture with NK cells. Nevertheless, the addition of NK cells mediated a 60 to 80% reduction in the CFU level of intracellular M. tuberculosis at the same time point. This discrepancy could indicate that the killing of intracellular M. tuberculosis is not tied to NK cell-mediated monocyte apoptosis. Alternatively, it may be that bacterial killing is a more rapid effect of the relevant apoptotic pathways than the DNA splicing which results in positive TUNEL staining. In this case, the timing of our assays could underestimate the ultimate extent of MN apoptosis occurring within the cultures. An ad- ditional possibility is that the apoptosis of some cells serves to activate effector functions of nonapoptotic MN, resulting in bacterial killing. This latter mechanism has been described in in vitro studies of MN infection with M. avium (14) . Previous studies had indicated that infection with virulent M. tuberculosis increases the resistance of isolated MN to apoptosis and that this resistance is based on increased production of soluble tumor necrosis factor (TNF) receptor by the infected cells (1). Our fluorescent microscopy studies indicate that MN infected with virulent H37Rv are susceptible to NK cell-mediated apoptosis. Because of the apparent specificity of these previous observations for TNF-mediated apoptosis, however, our findings do not necessarily contradict this earlier report.
Because of the possible relationship of the observed NK cell-mediated apoptosis to the killing of intracellular M. tuberculosis, we investigated a possible role of the interaction of FasL and Fas in this killing. Our studies showed that blocking of this apoptotic pathway had no effect on the ability of NK cells to mediate the killing of intracellular M. tuberculosis or upon NK cell-mediated apoptosis of BCG-infected MN. In addition to FasL, however, NK cells have recently been shown to express other apoptosis-inducing surface ligands, including membrane-bound TNF (23), TRAIL (TNF-related apoptosisinducing ligand) (46) , and CD40L (9). Our findings suggest that NK cell-induced apoptosis of infected MN is mediated by these or other as-yet-undescribed pathways and may be linked to the killing of intracellular M. tuberculosis.
In summary, unstimulated NK cells from both PPD-positive and PPD-negative subjects can mediate the early killing of intracellular M. tuberculosis H37Rv. This killing, which takes place within the first 24 h of coculture, is not associated with the production of IFN-␥ by NK cells and does not require the release of NK cell cytotoxic granules, but it is associated with the induction of NK cell-mediated MN apoptosis. 
